EUR 2.36
(-0.84%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 952.69 Thousand EUR | 94.7% |
2022 | 489.31 Thousand EUR | -20.37% |
2021 | 614.49 Thousand EUR | -24.07% |
2020 | 809.29 Thousand EUR | -19.21% |
2019 | 1 Million EUR | 12.23% |
2018 | 892.57 Thousand EUR | 41.64% |
2017 | 630.17 Thousand EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 342.97 Thousand EUR | 0.0% |
2023 Q4 | 952.69 Thousand EUR | 0.0% |
2023 Q2 | 522.32 Thousand EUR | 0.0% |
2023 FY | 952.69 Thousand EUR | 94.7% |
2022 Q2 | 551.09 Thousand EUR | 0.0% |
2022 Q4 | 489.31 Thousand EUR | 0.0% |
2022 FY | 489.31 Thousand EUR | -20.37% |
2021 Q4 | 614.49 Thousand EUR | 0.0% |
2021 FY | 614.49 Thousand EUR | -24.07% |
2021 Q2 | 746.86 Thousand EUR | 0.0% |
2020 Q2 | 963.68 Thousand EUR | 0.0% |
2020 Q4 | 809.29 Thousand EUR | 0.0% |
2020 FY | 809.29 Thousand EUR | -19.21% |
2019 Q2 | 1.14 Million EUR | 0.0% |
2019 Q4 | 1 Million EUR | 0.0% |
2019 FY | 1 Million EUR | 12.23% |
2019 Q3 | - EUR | -100.0% |
2018 Q4 | 892.57 Thousand EUR | 0.0% |
2018 FY | 892.57 Thousand EUR | 41.64% |
2017 FY | 630.17 Thousand EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Philogen S.p.A. | 14.91 Million EUR | 93.613% |
Ulisse Biomed S.p.A. | 496.77 Thousand EUR | -91.774% |